| Name | Impact Healthcare Reit |
|---|---|
| Epic | IHR |
| Isin | GB00BYXVMJ03 |
| Index | MID300 |
| Industry | Real Estate Investment Trusts |
| Latest share price | 87.30p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £361.74 | Debt ratio | n/a |
| Shares in issue | 414.37 | Debt-to-equity ratio | n/a |
| P/E ratio | 12.4 | Assets / equity ratio | n/a |
| Total dividends per share | 6.77p | Price to book value | n/a |
| Dividend yield | 7.5 | ROCE | n/a |
| Dividend cover | 1.08 | EPS growth | 2 |
| Earning per share | 11.79 | 52-week high / low | 78.90p / 92.60p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| 4th Interim | 2024-02-08 | 2024-02-23 | 1.6925p |
| 3rd Interim | 2023-11-02 | 2023-11-24 | 1.6925p |
| 2nd Interim | 2023-08-17 | 2023-09-20 | 1.6925p |
| 1st Interim | 2023-05-04 | 2023-05-19 | 1.6925p |
| 4th Interim | 2023-02-09 | 2023-02-24 | 1.635p |
| 3rd Interim | 2022-11-03 | 2022-11-25 | 1.635p |
| 2nd Interim | 2022-08-25 | 2022-09-09 | 1.635p |
| 1st Interim | 2022-05-05 | 2022-05-20 | 1.635p |
| 4th Interim | 2022-02-24 | 2022-03-11 | 1.6025p |
| Company name | Impact Healthcare Reit |
|---|---|
| Address | The Scalpel, 18th Floor, 52 Lime Street, London, United Kingdom, EC3M 7AF |
| Telephone | +44(0)207 409 0181 |
| Website | http://www.impactreit.uk |
| Director | Position |
|---|---|
| Mr Simon T Laffin | Non-Executive Chairman |
| Ms Rosemary Boot | Senior Independent Non-Executive Director |
| Ms Amanda Aldridge | Independent Non-Executive Director |
| Mr Chris Santer | Independent Non-Executive Director |
| Mr Cedi Frederick | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 656.99 | 572.45 | 499.68 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | 0.91 | 1.18 | 1.56 |
| Cash and equivalents | 9.39 | 22.53 | 13.26 |
| Other current assets and asset held for resale | n/a | 0.36 | n/a |
| Total of all assets | 667.29 | 596.52 | 514.5 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 6.91 | 23.94 | 6.7 |
| Long term liabilities | 182.27 | 126.66 | 113.55 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 189.18 | 150.6 | 120.25 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 478.11 | 445.92 | 394.24 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 4.14 | 4.05 | 3.51 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | 73.17 | 52.15 | 60.99 |
| Share premium account | 376.72 | 365.64 | 305.67 |
| Total equity | 478.11 | 445.92 | 394.24 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 57.06 | 19.1 | 35.16 |
| Pre-tax profit | 48.83 | 16.89 | 31.97 |